These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 23183131)

  • 1. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients.
    Stelzhammer V; Guest PC; Rothermundt M; Sondermann C; Michael N; Schwarz E; Rahmoune H; Bahn S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1199-207. PubMed ID: 23183131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
    Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
    Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Kirov R; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2014 Oct; 57():117-24. PubMed ID: 25073431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
    Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
    Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial.
    Brakemeier EL; Merkl A; Wilbertz G; Quante A; Regen F; Bührsch N; van Hall F; Kischkel E; Danker-Hopfe H; Anghelescu I; Heuser I; Kathmann N; Bajbouj M
    Biol Psychiatry; 2014 Aug; 76(3):194-202. PubMed ID: 24462229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipid profile changes after successful treatment with electroconvulsive therapy in major depression: A prospective pilot trial.
    Aksay SS; Bumb JM; Janke C; Biemann R; Borucki K; Lederbogen F; Deuschle M; Sartorius A; Kranaster L
    J Affect Disord; 2016 Jan; 189():85-8. PubMed ID: 26426831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
    Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.
    Minelli A; Maffioletti E; Bortolomasi M; Conca A; Zanardini R; Rillosi L; Abate M; Giacopuzzi M; Maina G; Gennarelli M; Bocchio-Chiavetto L
    Acta Psychiatr Scand; 2014 Jun; 129(6):461-6. PubMed ID: 23957507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy.
    Neyazi A; Theilmann W; Brandt C; Rantamäki T; Matsui N; Rhein M; Kornhuber J; Bajbouj M; Sperling W; Bleich S; Frieling H; Löscher W
    Transl Psychiatry; 2018 Jan; 8(1):25. PubMed ID: 29353887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
    Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
    Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.
    Stelzhammer V; Haenisch F; Chan MK; Cooper JD; Steiner J; Steeb H; Martins-de-Souza D; Rahmoune H; Guest PC; Bahn S
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1599-608. PubMed ID: 24901538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only.
    Haghighi M; Salehi I; Erfani P; Jahangard L; Bajoghli H; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2013 Jul; 47(7):908-15. PubMed ID: 23583029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of cytokine profiles during electroconvulsive therapy in patients with major depression.
    Rotter A; Biermann T; Stark C; Decker A; Demling J; Zimmermann R; Sperling W; Kornhuber J; Henkel A
    J ECT; 2013 Sep; 29(3):162-9. PubMed ID: 23609520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.
    Ryan KM; Dunne R; McLoughlin DM
    Brain Stimul; 2018; 11(5):1123-1131. PubMed ID: 29802070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
    Rasmussen KG; Mueller M; Rummans TA; Husain MM; Petrides G; Knapp RG; Fink M; Sampson SM; Bailine SH; Kellner CH
    J Clin Psychiatry; 2009 Feb; 70(2):232-7. PubMed ID: 19192459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
    Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
    J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
    Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
    J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.